Human papillomavirus infection

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 139-143

  Huh, Warner K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

CANCER SCREENING; DISEASE COURSE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; NOTE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REINFECTION; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS; WOMEN'S HEALTH;

ADOLESCENT; ADULT; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 67651030811     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181ab6878     Document Type: Note

References (16)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Path 2002;55:244-65.
2. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. IntJ Cancer 2007;121:621-32.
3. Franco EL, Harper DM. Vaccination against human papillo-mavirus infection: a new paradigm in cervical cancer control. Vaccine 2005;23(17-18):2388-94.
4. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
5. Herzog TJ, Monk BJ. Reducing the burden of glandular carcinomas of the uterine cervix. AmJ Obstet Gynecol 2007; 197:566-71.
6. Kanodia S, Fahey LM, Kast WM. Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 2007;7:79-89.
7. Wright TC Jr. HPV DNA testing for cervical cancer screening. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(suppl 1): S239-46.
8. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am JEpidemiol 2008;168:123-37.
9. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337: 76-84.
10. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006;24(suppl 3):S42-51.
11. Stanley M. HPV: a master at avoiding the hosts defenses. HPV Today 2007;11:1-16. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;79:321-7.
12. Morrison EA, Dole P, Sun XW, Stern L, Wright TC Jr. Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients. Nephrol Dial Transplant 1996;11: 1603-6.
13. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005;97:577-86.
14. Morrison EA. Natural history of cervical infection with human papillomaviruses. Clin Infect Dis 1994;18:172-80.
15. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
16. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N EnglJ Med 1998;338:423-8.